PharmSky Research is a Melbourne-based pharmaceutical contract development and manufacturing organisation (CDMO) helping innovators turn discoveries into registered medicines. Operating from TGA-licensed GMP facilities in Dandenong South, Victoria, PharmSky takes an adaptive approach to formulation development, rapidly producing multiple formulation and delivery options to support faster clinical evaluation. Services include product design, complex formulation, analytical method development and validation, stability studies, process optimisation, clinical trial manufacturing, and regulatory support. Capabilities span sterile injectables, oral solutions, emulsions, and topicals, with specialist strength in nanotechnology-enabled delivery and complex generics. Backed by leadership with 25+ years' experience, PharmSky partners globally to accelerate development.